HPM Web Site

  • HPM Web Site

Get Updates via E-mail

  • Enter your email address to automatically receive new posts to the FDA Law Blog via e-mail.

    Delivered by FeedBurner

 Subscribe in a reader




Disclaimer

  • FDA Law Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of FDA Law Blog does not create an attorney-client relationship. FDA Law Blog is the blog of Hyman, Phelps & McNamara, P.C. (“HPM”) and it is intended primarily for other attorneys and regulatory professionals. No part of FDA Law Blog --whether information, commentary, or other-- may be attributed to HPM's clients. Readers should be aware that HPM represents many companies in the food, drug, medical device, and health care industries, and therefore FDA Law Blog may occasionally report on news that relates to HPM clients. FDA Law Blog will always strive to be unbiased in its reporting. All information on FDA Law Blog should be double-checked for its accuracy and current applicability.

    Copyright 2011 Hyman, Phelps & McNamara, P.C.

Awards & Honors










« Fecal Microbiota Transplantation: FDA Announces Limited Enforcement Discretion | Main | Getting to the Bottom of the Bottomley Case? »

July 23, 2013

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341d150c53ef0192ac27f437970d

Listed below are links to weblogs that reference FDA Racks Up a Circuit Court Loss in Imported and Unapproved Thiopental Sodium Case; Will It Jeopardize FDA’s Drug Shortage Program?:

Comments

Jim O'Reilly

Kurt, I think "apodictically" belongs in a spelling bee or a Mensa competition. Doug's outgoing law clerk probably smiled as he/she slipped it into the opinion. But I'm glad of the timing as I'll now have time to rewrite the "discretion" portion of the enforcement chapter in the new 4th edition of West's Food & Drug Administration treatise. This looms large as a hit against the deliberate desuetude (take that, pedants!) of FDA in the face of statutory language. The Heckler discretion angle failed, making FDA more vulnerable to challengers in future cases of inactivity...an interesting twist indeed. -- Prof. Jim O'Reilly

The comments to this entry are closed.

180-Day Exclusivity Tracker

Citizen Petition Tracker

REMS Tracker

Legislation Tracker